This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
Doxazosin — Description, Dosage, Side Effects | PillsCard
OTC
Doxazosin
4 mg, Tabletki
INN: Doxazosinum
Data updated: 2026-04-24
Available in:
🇩🇪🇬🇧🇫🇷🇵🇱🇵🇹🇺🇦
Form
Tabletki
Dosage
4 mg
Route
—
Storage
Recommended Storage: Store at 25°C (77°F); excursions permitted from 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].
About This Product
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
Manufacturer
Delfarma Sp. z o.o.
ATC Code
G04CA + C02CA04
Source
URPL
11 DESCRIPTION Doxazosin mesylate is a quinazoline compound that is a selective inhibitor of the alpha 1 subtype of alpha-adrenergic receptors. The chemical name of doxazosin mesylate is 1-(4-amino-6,7- dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl) piperazine methanesulfonate. The empirical formula for doxazosin mesylate is C 23 H 25 N 5 O 5 • CH 4 O 3 S and the molecular weight is 547.6. It has the following structure: Doxazosin mesylate is freely soluble in dimethylsulfoxide, soluble in dimethylformamide, slightly soluble in methanol, ethanol, and water (0.8% at 25°C), and very slightly soluble in acetone and methylene chloride. Each doxazosin tablet, USP, for oral administration, contains 1 mg, 2 mg, 4 mg and 8 mg of doxazosin as the free base. In addition, each doxazosin tablet, USP contains the following inactive ingredients: croscarmellose sodium, lactose monohydrate, magnesium stearate and microcrystalline cellulose. doxazosin-structure.jpg
⚠️ Warnings
•Prostate cancer should be ruled out before starting therapy.
• Orthostatic hypotension may occur at the initiation of therapy or when there is dose increase.
• Avoid driving or performing hazardous tasks for 24 hour after starting therapy or dose changes.
• Consult with your doctor during Pregnancy and breastfeeding.